Learn the essential early warning signs of leukemia that are often dismissed as everyday ailments but could be indicators of ...

My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...

Black women with chronic myeloid leukemia face unique challenges when it comes to diagnosis, treatment, and overall disease ...

Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia Sep. 17, 2024 — According to new research, 80% of patients with previously untreated or relapsed/refractory ...

CAR-T cell therapy has revolutionized the treatment of relapsed and refractory B-acute lymphoblastic leukemia (B-ALL), with ...

For Black Americans, the battle with Chronic Myeloid Leukemia is marked by unique survival challenges and treatment ...

Open label study in forty AML and MDS patients Study financed by the US Department of Defense Cantargia (Cantargia AB; Nasdaq ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

Swedish company Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals ...

Driven by a steady influx of retirees, Florida now has the highest leukemia rates of any U.S. state and the disease is the ...

Oliver’s birthday was in jeopardy of being overshadowed by his diagnosis and isolation. Instead, Oliver was treated to an ...